A surgical procedure is guided by a real-time fluorescence image of the operative area created using the medical imaging approach known as fluorescence guided surgery (FGS). FGS is a promising medical technique that might enhance patient outcomes and alter the way reconstructive and oncological treatments are carried out in the future. Fluorescence guided surgery is much more affordable and simple to use than conventional medical imaging methods, and the system may offer real-time imaging while an operation is being performed. Thus, FGS is being employed in a variety of surgical settings.
Market Statistics:
By the end of 2022, the market for fluorescence guided surgery systems is anticipated to be worth US$ 79.0 Mn.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5286
Drivers:
The global market for fluorescence guided surgery systems is anticipated to develop over the course of the projected period due to an increase in demand for these systems across the globe. For instance, FGS is an imaging technology that enables surgeons to see various structures and types of tissue that might not be as evident under white light settings during a surgery. UC San Diego opened a centre for fluorescence-guided surgery in December 2019. With the use of the facility, surgeons will be able to treat patients with cancers and difficult diseases of various kinds with precision akin to GPS.
Opportunities:
Players in the fluorescence guided surgery systems market can expect to see tremendous growth prospects due to the rising cancer burden in the world. FGS, for example, is a life-saving imaging technology that illuminates tumours, cancer cells, nerves, and other anatomical characteristics for simpler diagnosis and exact removal or preservation during surgeries. Age-related risk accumulation for particular cancers is most likely the cause of the sharp rise in cancer prevalence. The World Health Organization (WHO) estimates that cancer will be the primary cause of roughly 10 million deaths globally in 2020.
Restraints:
Fluorescence guided surgery systems are predicted to see slow growth because to a strict regulatory environment, fluoroscopy side effects, and a shortage of qualified specialists. For instance, fluoroscopy, which creates images of the body using ionising radiation, carries hazards, just as it does in many other fields of medicine. Radiation exposure carries risks that include include cancers that can develop later in life as well as damage to the skin and underlying tissues (burns), which can happen right away.
Impact:
Due to the COVID-19 pandemic’s limited resources and the vulnerability of cancer patients to the virus, fewer fluorescence-guided surgeries were performed during the pandemic, which had a significant negative effect on the market for fluorescence guided surgery equipment. Additionally, certain cancer patients who get COVID-19 may be more susceptible to developing a major infection since the malignancy and its treatments have compromised their immune systems. However, the recent introduction of fluorescence guided surgery in cancer surgery suggests that oncological techniques may change in the future. This is thus anticipated to fuel market expansion.
Key Takeaways:
The market for fluorescence guided surgery systems was valued at US$ 67.8 Mn in 2021 and is anticipated to grow at a CAGR of 16.6% from 2022 to 2028 to reach US$ 199.0 Mn.
In terms of Type, the SPY system segment dominated the global market for fluorescence guided surgical systems in 2022, with a 43.2% market share in terms of value. Increasing product approval and launches are anticipated to fuel segment expansion over the course of the projected period.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5286
Market Trends:
It is anticipated that FGS systems would eventually replace more traditional techniques for identifying different tissue types and structures during surgical procedures. FGS is also significantly cheaper and simpler to use than traditional medical imaging methods like CT and MRI, and it can give real-time imaging during surgery. Fluorescence guided surgery (FGS) systems have become more popular as a result, and this trend is anticipated to continue during the forecast period, fueling the market’s expansion.
Competitive Landscape:
The leading companies in the global market for fluorescence guided surgery systems are
Olympus Corporation, Irillic Pvt. Ltd., Shimadzu Corporation, Gentige, Stryker Corporation, OnLume Inc., Hamamatsu Photonics KK, and Medtronic PLC are among the companies involved.
Recent Developments
With the introduction of POWER SEAL advanced bipolar surgical energy devices in September 2021, Olympus expanded its surgical product line. The power seal products helped Olympus gain a competitive edge in the expanding international market for cutting-edge bipolar surgical energy devices.
Stryker bought Wright Medical Group NV in November 2020. Through this acquisition, Stryker’s position in the global market for trauma and extremities was strengthened, opening us significant prospects to drive innovation and serve more patients.
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Fluorescence Guided Surgery Systems Market Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Fluorescence Guided Surgery Systems Market Industry Impact
Chapter 2 Global Fluorescence Guided Surgery Systems Market Competition by Types, Applications, and Top Regions and Countries
2.1 Global Fluorescence Guided Surgery Systems Market (Volume and Value) by Type
2.3 Global Fluorescence Guided Surgery Systems Market (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Fluorescence Guided Surgery Systems Market Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 6 East Asia Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 7 Europe Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 8 South Asia Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 9 Southeast Asia Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 10 Middle East Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 11 Africa Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 12 Oceania Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 13 South America Fluorescence Guided Surgery Systems Market Market Analysis
Chapter 14 Company Profiles and Key Figures in Fluorescence Guided Surgery Systems Market Business
Chapter 15 Global Fluorescence Guided Surgery Systems Market Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5286
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com